{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-034510","form_type":"8-K","ticker":"AVTX","cik":"0001534120","company_name":"Avalo Therapeutics, Inc.","filed_at":"2023-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.408791+00:00","generated_at":"2026-06-09T22:36:37.608345+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Avalo Therapeutics lowers stockholder meeting quorum from majority to one-third","bullets":["Board approved Fourth Amended and Restated Bylaws on October 16, 2023, effective immediately.","Quorum reduced to one-third of shares entitled to vote, present in person or by proxy.","Previous requirement was a majority of shares present in person or by proxy."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-034510","json":"https://secwatch.observer/filing/0001628280-23-034510.json","markdown":"https://secwatch.observer/filing/0001628280-23-034510.md","text":"https://secwatch.observer/filing/0001628280-23-034510.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534120/000162828023034510/0001628280-23-034510-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534120/000162828023034510/avtx-20231016.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T22:36:37.608345+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d029f4486b3d899d9068bcff2d04e0ef92032b2b","claim":"Avalo Therapeutics, Inc.: Amended quorum requirement for stockholder meetings from majority of shares present to one-third of shares entitled to vote (effective 2023-10-16).","evidence_excerpt":"On October 16, 2023, the Board of Directors of Avalo Therapeutics, Inc. (the “Company”) approved the Company’s Fourth Amended and Restated Bylaws, effective immediately upon approval by the Board (the “Amended and Restated Bylaws”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534120/000162828023034510/0001628280-23-034510-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-10-16"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}